Vietnam
· Delayed Price · Currency is VND HNX: MKV Statistics
Total Valuation
Cai Lay Veterinary Pharmaceutical JSC has a market cap or net worth of VND 47.50 billion. The enterprise value is 26.33 billion.
| Market Cap | 47.50B |
| Enterprise Value | 26.33B |
Important Dates
The last earnings date was Sunday, January 19, 2025.
| Earnings Date | Jan 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Cai Lay Veterinary Pharmaceutical JSC has 5.00 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 5.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.22% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 6.44.
| PE Ratio | 6.44 |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| PB Ratio | 0.54 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 3.57 |
| EV / Sales | 0.24 |
| EV / EBITDA | 1.61 |
| EV / EBIT | 2.17 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.53
| Current Ratio | 3.53 |
| Quick Ratio | 2.75 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 314.90 |
Financial Efficiency
Return on equity (ROE) is 8.84% and return on invested capital (ROIC) is 9.08%.
| Return on Equity (ROE) | 8.84% |
| Return on Assets (ROA) | 7.31% |
| Return on Capital (ROIC) | 9.08% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.06 |
| Inventory Turnover | 4.80 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.40% in the last 52 weeks. The beta is 0.59, so Cai Lay Veterinary Pharmaceutical JSC's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | +4.40% |
| 50-Day Moving Average | 9,314.00 |
| 200-Day Moving Average | 9,459.50 |
| Relative Strength Index (RSI) | 51.10 |
| Average Volume (20 Days) | 3,085 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cai Lay Veterinary Pharmaceutical JSC had revenue of VND 109.98 billion and earned 7.38 billion in profits. Earnings per share was 1,476.00.
| Revenue | 109.98B |
| Gross Profit | 38.88B |
| Operating Income | 12.13B |
| Pretax Income | 9.27B |
| Net Income | 7.38B |
| EBITDA | 16.36B |
| EBIT | 12.13B |
| Earnings Per Share (EPS) | 1,476.00 |
Balance Sheet
| Cash & Cash Equivalents | 21.17B |
| Total Debt | n/a |
| Net Cash | 21.17B |
| Net Cash Per Share | 4,235.00 |
| Equity (Book Value) | 87.20B |
| Book Value Per Share | 17,436.60 |
| Working Capital | 55.26B |
Cash Flow
| Operating Cash Flow | 10.56B |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 35.35%, with operating and profit margins of 11.03% and 6.71%.
| Gross Margin | 35.35% |
| Operating Margin | 11.03% |
| Pretax Margin | 8.43% |
| Profit Margin | 6.71% |
| EBITDA Margin | 14.88% |
| EBIT Margin | 11.03% |
| FCF Margin | n/a |
Dividends & Yields
Cai Lay Veterinary Pharmaceutical JSC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 15.54% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on January 9, 2013. It was a forward split with a ratio of 1.06.
| Last Split Date | Jan 9, 2013 |
| Split Type | Forward |
| Split Ratio | 1.06 |
Scores
Cai Lay Veterinary Pharmaceutical JSC has an Altman Z-Score of 3.75.
| Altman Z-Score | 3.75 |
| Piotroski F-Score | n/a |